Latest Articles
CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells - themarijuanaherald.com
CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells themarijuanaherald.com
Published: Sept. 23, 2026, 5:01 p.m.
CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells - The Marijuana Herald
CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells The Marijuana Herald
Published: Sept. 23, 2026, 5:01 p.m.
A combination of drugs shows efficacy against endometrial - Hospital Universitari Vall d'Hebron
A combination of drugs shows efficacy against endometrial Hospital Universitari Vall d'Hebron
Published: Sept. 18, 2026, 3:47 p.m.
A combination of drugs shows efficacy against endometrial - Vall d'Hebron Barcelona Hospital Campus
A combination of drugs shows efficacy against endometrial Vall d'Hebron Barcelona Hospital Campus
Published: Sept. 18, 2026, 9:47 a.m.
Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now - Black Doctor
Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now Black Doctor
Published: Sept. 9, 2026, 8:33 p.m.
Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now - blackdoctor.com
Op-Ed: Endometriosis and Preeclampsia: A Dangerous Combination for Black Women That Researchers Have Been Looking Away From — Until Now blackdoctor.com
Published: Sept. 9, 2026, 8:33 p.m.
Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain - Patient Care Online
Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain Patient Care Online
Published: Aug. 26, 2026, 6:39 p.m.
Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain - Contemporary OB/GYN
Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain Contemporary OB/GYN
Published: Aug. 26, 2026, 12:20 p.m.
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years MSN
Published: June 8, 2026, 8:37 p.m.
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients News-Medical
Published: May 30, 2026, 2:16 a.m.
Link copied to clipboard!